Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, Tatva Chintan Pharma Chem has informed that it enclosed the transcript of the earnings call held on 28 January 2025 post announcement of financial results of the Company for the quarter and nine months ended 31 December 2024. The above information shall be made available on the website of the Company at www.tatvachintan.com.
The above information is a part of company’s filings submitted to BSE.